Cytosorbents CorporationCTSONASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank80
3Y CAGR-5.9%
5Y CAGR+2.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-5.9%/yr
vs +16.5%/yr prior
5Y CAGR
+2.3%/yr
Recent deceleration
Acceleration
-22.5pp
Decelerating
Percentile
P80
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $43.50M | +3.8% |
| 2024 | $41.91M | -22.2% |
| 2023 | $53.90M | +3.2% |
| 2022 | $52.25M | +0.9% |
| 2021 | $51.81M | +33.6% |
| 2020 | $38.77M | +12.8% |
| 2019 | $34.38M | +21.3% |
| 2018 | $28.35M | +60.1% |
| 2017 | $17.71M | +12.5% |
| 2016 | $15.74M | - |